The Global Obesity Treatment Market was valued at US$5.55 billion in the year 2018 and is estimated to reach US$14.66 billion by 2026, at a CAGR of 12.92%.
Obesity can be denoted as a condition where excessive fat accumulation is seen in the body that leads to associated health risks such as cardio vascular diseases, diabetes, orthopedic disorders, etc. Previously, it was thought that obesity was prevalent only in the high-income countries. However, this has drastically changed in the recent times where the rate of obesity is increasing even in the middle- and low-income countries. It is also a fact that >30% of the world’s population are either overweight or obese. It includes even the adolescent population. This rise in obesity can be attributed to several factors such as sedentary lifestyle, change in the eating habits, lack of physical activities, stress, hypertension, age, etc. These factors are expected to drive the obesity treatment market. Besides obesity and weight management has become a major commercial sector due to technological advancements, initiatives taken by both the government and private sectors, more awareness on obesity related problems on health.
In the past physical exercise and diet is prescribed for weight and obesity management. But the advancements had led to the introduction of minimally invasive weight management procedures and surgeries, drugs and combination of drugs that brings about satiety. As far as surgical procedure is concerned gastric bypass is one of the preferred one over the endoscopic procedure which involves implanting devices for satiety and gastric emptying. This is expected to drive the market in the forecast period. Further, the spending on healthcare and fitness had increased drastically in the recent decade which is also one factor that is expected to contribute to the market share in the upcoming years.
Also, the competition among the players driven by technological advancements and viable marketing strategies are driving the market. With hospitals and clinics participating in obesity management services, the market is reaching to all corners with a demand for minimally invasive procedure.
The North American market is set to hold the major share among the regions with more than 50% owing to rising incidence of obesity. However, Asia Pacific region with increase in population and obesity associated disorders is set to contribute more to the market share. Combinatorial therapies held >50% of the market in drug market while gastric bypass procedure dominated with over 30% of the market share in devices and surgical segment.
The companies which are avidly involved in obesity treatment are classified as Major, Minor, Emerging and New Entrant based on several market parameters. More than 35 companies have been enlisted in the report that involves both pharma and device-based companies. This includes Medtronic, Stryker Corp, Zimmer Biomet, Getinge AB, Smith & Nephew, Coloplast A/S, Arena Pharmaceuticals Inc, Vivus Inc, Allergan Inc, F Hoffman La Roche, EnteroMedics Inc., Orexigen Therapeutics Inc, Novo Nordisk A/S, USGI Medical Inc, and many more…
Optima Insights had segmented the key components of the report by Drugs (Combinatorial Drugs, Appetite Suppressants, Malabsorption, Satiety Based); Surgery & Devices (Gastric Banding Adjustment, Gastric Bypass, Sleeve Gastrectomy, Biliopancreatic Diversion and Endoscopy) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
Research Scope

• Provides detailed Analysis of the Market Structure along with forecast of the various segments and sub-segments.

• Provides a Comparative Analysis of Key Marketed and Pipeline Products.

• Provides Key Information on Players involved.

• Provides a Complete Overview of Market Segments and the Regional Outlook.

• Provides In-depth Coverage of Key News, including Major Mergers, Acquisitions and Product Development updates such as clinical trial progression updates and regulatory updates.
The Report Provides Key Insights on
• History of the Obesity Treatment Market, 2015 to 2017
• Forecast of the Obesity Treatment Market Growth till the year 2026
• The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Obesity Treatment Market
• Analysis of potential growth segments which will drive the market
• Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market
• Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics
About Us
Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.
Contact
Optima Insights
Mr Chucks G
+91 966 6620 365 (Asia) | +1 424 2554 365 (US)
Email: [email protected]
https://www.optimainsights.org